Comparison 21. Controlled release prostaglandins (vaginal insert) versus injectable uterotonics.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Nausea	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	4.5 [1.00, 20.31]
1.1 Dinoprostone 0.3 mg/hr	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	4.5 [1.00, 20.31]
2 Diarrhoea	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.12, 72.77]
2.1 Dinoprostone 0.3 mg/hr	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.12, 72.77]
3 Pyrexia (>= 38 C)	1	200	Odds Ratio (M‐H, Fixed, 95% CI)	3.03 [0.12, 75.28]
3.1 Dinoprostone 0.3 mg/hr	1	200	Odds Ratio (M‐H, Fixed, 95% CI)	3.03 [0.12, 75.28]
4 Shivering	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.12, 72.77]
4.1 Dinoprostone 0.3 mg/hr	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.12, 72.77]